Carlos Rojas-Fernandez

Summary

Affiliation: University of Waterloo
Location: Waterloo, Canada
URL: http://www.the-ria.ca/research/profile_roj-c.cfm
Publications:
1. Robb AS, Andersson C, Bellochio EE, Manos G, Rojas-Fernandez C, Mathew S, et al. Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old): Results from a pooled analysis of 2 studies. Prim Care Companion CNS Disord 2011;13(1):e1-e9.
2. Rojas-Fernandez CH. Fundamentals of Geriatric Pharmacotherapy: An evidence based approach. Book review in Annals of Pharmacotherapy 2010;44:1857-58.
2: Rojas-Fernandez CH, Miller LJ, Sadowski CA. Considerations in the treatment of
geriatric depression: Overview of pharmacotherapeutic and psychotherapeutic
treatment interventions. Res Gerontol Nurs. 2010 Jul;3(3):176-86. doi:
10.3928/--01. Epub 2010 Jun 30. Review. Erratum in: Res Gerontol
Nurs. 2010 Oct;3(4):239. Dosage error in article text. PubMed PMID: .


3: Rojas-Fernandez CH, Moorhouse P. Current concepts in vascular cognitive
impairment and pharmacotherapeutic implications. Ann Pharmacother. 2009
Jul;43(7):1310-23. Epub 2009 Jul 7. Review. PubMed PMID: .


5: Rojas-Fernandez CH, Lapane KL, MacKnight C, Howard KA. Undertreatment of
osteoporosis in residents of nursing homes: population-based study with use of
the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database.
Endocr Pract. 2002 Sep-Oct;8(5):335-42. PubMed PMID: .


6: Rojas-Fernandez CH. Inappropriate medications and older people: has anything
changed over time? Ann Pharmacother. 2003 Jul-Aug;37(7-8):1142-4. PubMed PMID:
.


7: Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical
pharmacists of behavioral and psychological symptoms of dementia in nursing home
residents: results from a pilot study. Pharmacotherapy. 2003 Feb;23(2):217-21.
PubMed PMID: .


8: Xu KT, Rojas-Fernandez CH. Ancillary community pharmacy services provided to
older people in a largely rural and ethnically diverse region: a survey of
consumers in West Texas. J Rural Health. 2003 Winter;19(1):79-86. PubMed PMID:
.


9: Rojas-Fernandez CH, Chen M, Fernandez HL. Implications of amyloid precursor
protein and subsequent beta-amyloid production to the pharmacotherapy of
Alzheimers disease. Pharmacotherapy. 2002 Dec;22(12):1547-63. Review. PubMed
PMID: .


10: Sleeper RB, Rojas-Fernandez C. Underutilization of aspirin for secondary
prophylaxis of cardiovascular disease in a long-term-care facility. Am J Health
Syst Pharm. 2002 Jul 1;59(13):1294-5. PubMed PMID: .


11: Lane LA, Rojas-Fernandez C. Treatment of vitamin b(12)-deficiency anemia:
oral versus parenteral therapy. Ann Pharmacother. 2002 Jul-Aug;36(7-8):1268-72.
Review. PubMed PMID: .


12: Seifert CF, Johnston BA, Rojas-Fernandez C. Drug administration through
enteral feeding catheters. Am J Health Syst Pharm. 2002 Feb 15;59(4):378-9.
PubMed PMID: .


13: Macknight C, Rojas-Fernandez CH. Celecoxib- and rofecoxib-induced delirium. J
Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):305-6. PubMed PMID: .


14: Rojas-Fernandez CH. Successful use of donepezil for the treatment of dementia
with Lewy bodies. Ann Pharmacother. 2001 Feb;35(2):202-5. PubMed PMID: .


15: Rojas-Fernandez CH, Lanctot KL, Allen DD, MacKnight C. Pharmacotherapy of
behavioral and psychological symptoms of dementia: time for a different paradigm?
Pharmacotherapy. 2001 Jan;21(1):74-102. Review. PubMed PMID: .


16: Rojas-Fernandez C, Thomas VS, Carver D, Tonks R. Suboptimal use of
antidepressants in the elderly: a population-based study in Nova Scotia. Clin
Ther. 1999 Nov;21(11):1937-50. PubMed PMID: .


17: MacKnight C, Rojas-Fernandez C. Quetiapine for sexually inappropriate
behavior in dementia. J Am Geriatr Soc. 2000 Jun;48(6):707. PubMed PMID:
.


18: Haase KK, Rojas-Fernandez CH, Lane L, Frank DA. Potential interaction between
celecoxib and warfarin. Ann Pharmacother. 2000 May;34(5):666-7. PubMed PMID:
.


19: Rojas-Fernandez C. Drug interactions and donepezil. J Am Geriatr Soc. 2000
May;48(5):597-8. PubMed PMID: .


20: Sleeper R, Bond CA, Rojas-Fernandez C. Psychotropic drugs and falls: new
evidence pertaining to serotonin reuptake inhibitors. Pharmacotherapy. 2000
Mar;20(3):308-17. Review. PubMed PMID: .


21: Rojas-Fernandez CH, MacKnight C. Comment: management of Alzheimer disease.
Ann Pharmacother. 1999 Dec;33(12):1374-5. PubMed PMID: .


22: Rojas-Fernandez CH, Carver D, Tonks R. Population trends in the prevalence of
benzodiazepine use in the older population of Nova Scotia: A cause for concern?
Can J Clin Pharmacol. 1999 Autumn;6(3):149-56. PubMed PMID: .


23: Rojas-Fernandez CH, MacKnight C. Dementia with Lewy bodies: review and
pharmacotherapeutic implications. Pharmacotherapy. 1999 Jul;19(7):795-803.
Review. PubMed PMID: .


24: Rojas-Fernandez CH, Kephart GC, Sketris IS, Kass K. Underuse of
acetylsalicylic acid in individuals with myocardial infarction, ischemic heart
disease or stroke: data from the 1995 population-based Nova Scotia Health Survey.
Can J Cardiol. 1999 Mar;15(3):291-6. PubMed PMID: .


25: Rojas-Fernandez C, Mallery L. Indomethacin is inappropriate for use in the
geriatric population. Ann Pharmacother. 1998 Sep;32(9):980. PubMed PMID: 9762388.


26: Rojas-Fernandez C, Gordon J. Selective serotonin reuptake inhibitor
discontinuation syndrome: putative mechanisms and prevention strategies. Can J
Psychiatry. 1998 Jun;43(5):523-4. PubMed PMID: 9653540.

Publications

  1. ncbi Selective serotonin reuptake inhibitor discontinuation syndrome: putative mechanisms and prevention strategies
    C Rojas-Fernandez
    Can J Psychiatry 43:523-4. 1998
  2. ncbi Celecoxib- and rofecoxib-induced delirium
    C MacKnight
    J Neuropsychiatry Clin Neurosci 13:305-6. 2001
  3. ncbi Drug administration through enteral feeding catheters
    Charles F Seifert
    Am J Health Syst Pharm 59:378-9. 2002
  4. ncbi Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy
    Lenee A Lane
    College of Pharmacy, The University of Oklahoma Health Sciences Center, Norman Regional Hospital, Norman, OK, USA
    Ann Pharmacother 36:1268-72. 2002
  5. ncbi Underutilization of aspirin for secondary prophylaxis of cardiovascular disease in a long-term-care facility
    Rebecca B Sleeper
    Am J Health Syst Pharm 59:1294-5. 2002
  6. ncbi Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease
    Carlos H Rojas-Fernandez
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 Coulter, Amarillo, TX 79106 1712, USA
    Pharmacotherapy 22:1547-63. 2002
  7. ncbi Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: results from a pilot study
    Carlos H Rojas-Fernandez
    School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106 1712, USA
    Pharmacotherapy 23:217-21. 2003
  8. ncbi Undertreatment of osteoporosis in residents of nursing homes: population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database
    Carlos H Rojas-Fernandez
    Texas Tech University-Health Sciences Center-Amarillo, School of Pharmacy, 79106, USA
    Endocr Pract 8:335-42. 2002
  9. ncbi Current concepts in vascular cognitive impairment and pharmacotherapeutic implications
    Carlos H Rojas-Fernandez
    Bristol Myers Squibb Co US Pharmaceuticals Medical Affairs, Neuroscience, Gaithersburg, MD, USA
    Ann Pharmacother 43:1310-23. 2009
  10. ncbi Successful use of donepezil for the treatment of dementia with Lewy bodies
    C H Rojas-Fernandez
    School of Pharmacy, Department of Pharmacy Practice, Texas Tech University Health Sciences Center Amarillo, 79106 1712, USA
    Ann Pharmacother 35:202-5. 2001

Detail Information

Publications20

  1. ncbi Selective serotonin reuptake inhibitor discontinuation syndrome: putative mechanisms and prevention strategies
    C Rojas-Fernandez
    Can J Psychiatry 43:523-4. 1998
  2. ncbi Celecoxib- and rofecoxib-induced delirium
    C MacKnight
    J Neuropsychiatry Clin Neurosci 13:305-6. 2001
  3. ncbi Drug administration through enteral feeding catheters
    Charles F Seifert
    Am J Health Syst Pharm 59:378-9. 2002
  4. ncbi Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy
    Lenee A Lane
    College of Pharmacy, The University of Oklahoma Health Sciences Center, Norman Regional Hospital, Norman, OK, USA
    Ann Pharmacother 36:1268-72. 2002
    ..To evaluate the use of oral cyanocobalamin therapy in the treatment of cobalamin (vitamin B(12))-deficient anemia...
  5. ncbi Underutilization of aspirin for secondary prophylaxis of cardiovascular disease in a long-term-care facility
    Rebecca B Sleeper
    Am J Health Syst Pharm 59:1294-5. 2002
  6. ncbi Implications of amyloid precursor protein and subsequent beta-amyloid production to the pharmacotherapy of Alzheimer's disease
    Carlos H Rojas-Fernandez
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 Coulter, Amarillo, TX 79106 1712, USA
    Pharmacotherapy 22:1547-63. 2002
    ....
  7. ncbi Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: results from a pilot study
    Carlos H Rojas-Fernandez
    School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106 1712, USA
    Pharmacotherapy 23:217-21. 2003
    ..The service was well received by the facility staff and primary care providers. These preliminary results suggest that pharmacists can play an important role in the pharmacotherapy of BPSD with positive clinical outcomes...
  8. ncbi Undertreatment of osteoporosis in residents of nursing homes: population-based study with use of the Systematic Assessment of Geriatric Drug Use via Epidemiology (SAGE) database
    Carlos H Rojas-Fernandez
    Texas Tech University-Health Sciences Center-Amarillo, School of Pharmacy, 79106, USA
    Endocr Pract 8:335-42. 2002
    ..Although acceptable reasons may exist in some of these residents,others--especially the oldest old--may not be receiving adequate care...
  9. ncbi Current concepts in vascular cognitive impairment and pharmacotherapeutic implications
    Carlos H Rojas-Fernandez
    Bristol Myers Squibb Co US Pharmaceuticals Medical Affairs, Neuroscience, Gaithersburg, MD, USA
    Ann Pharmacother 43:1310-23. 2009
    ..To review evolution of the vascular cognitive impairment (VCI) construct, including diagnosis, pharmacotherapeutic implications, and address challenges that will shape future developments...
  10. ncbi Successful use of donepezil for the treatment of dementia with Lewy bodies
    C H Rojas-Fernandez
    School of Pharmacy, Department of Pharmacy Practice, Texas Tech University Health Sciences Center Amarillo, 79106 1712, USA
    Ann Pharmacother 35:202-5. 2001
    ..The benztropine was discontinued, and donepezil was increased to 10 mg/d. The patient's cognitive and functional status significantly improved, as did her visual hallucinations...
  11. ncbi Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?
    C H Rojas-Fernandez
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo 79106-1712, USA
    Pharmacotherapy 21:74-102. 2001
    ..Various advances in the neuropathophysiology and pharmacotherapy must be considered in the optimal design of regimens for patients with these symptoms...
  12. ncbi Indomethacin is inappropriate for use in the geriatric population
    C Rojas-Fernandez
    Ann Pharmacother 32:980. 1998
  13. ncbi Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: data from the 1995 population-based Nova Scotia Health Survey
    C H Rojas-Fernandez
    Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, TX, USA
    Can J Cardiol 15:291-6. 1999
    ..To determine current patterns of acetylsalicylic acid (ASA) use in Nova Scotia for individuals with self-reported myocardial infarction, stroke or ischemic heart disease...
  14. ncbi Dementia with Lewy bodies: review and pharmacotherapeutic implications
    C H Rojas-Fernandez
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo 79106 1712, USA
    Pharmacotherapy 19:795-803. 1999
    ..If these fail, neuroleptics may be prescribed with caution...
  15. ncbi Population trends in the prevalence of benzodiazepine use in the older population of Nova Scotia: A cause for concern?
    C H Rojas-Fernandez
    Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo 79106 1712, USA
    Can J Clin Pharmacol 6:149-56. 1999
    ..Although benzodiazepine use decreased, the observed patterns of use may place seniors at unnecessary risk for adverse health outcomes and increased health resource utilization...
  16. ncbi Comment: management of Alzheimer disease
    C H Rojas-Fernandez
    Ann Pharmacother 33:1374-5. 1999
  17. ncbi Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors
    R Sleeper
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center Lubbock, USA
    Pharmacotherapy 20:308-17. 2000
    ..It was thought that the agents did not increase the risk of falls, although recent evidence suggests that this is not the case...
  18. ncbi Drug interactions and donepezil
    C Rojas-Fernandez
    J Am Geriatr Soc 48:597-8. 2000
  19. ncbi Suboptimal use of antidepressants in the elderly: a population-based study in Nova Scotia
    C Rojas-Fernandez
    Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
    Clin Ther 21:1937-50. 1999
    ..Nearly half of the individuals studied appeared to be treated for inadequately short periods...
  20. ncbi Considerations in the treatment of geriatric depression: Overview of pharmacotherapeutic and psychotherapeutic treatment interventions
    Carlos H Rojas-Fernandez
    School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada
    Res Gerontol Nurs 3:176-86. 2010
    ..The purpose of this review is to discuss salient issues in geriatric depression, with a focus on pharmacotherapeutic and psychotherapeutic interventions...